323 related articles for article (PubMed ID: 21771026)
21. The developing spectrum of gastric-type cervical glandular lesions.
Talia KL; McCluggage WG
Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
[TBL] [Abstract][Full Text] [Related]
22. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia.
Xu JY; Hashi A; Kondo T; Yuminamochi T; Nara M; Hashi K; Murata S; Katoh R; Hoshi K
Int J Gynecol Pathol; 2005 Jul; 24(3):296-302. PubMed ID: 15968208
[TBL] [Abstract][Full Text] [Related]
23. Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features.
Ohta Y; Suzuki T; Hamatani S; Shiokawa A; Kushima M; Ota H
Pathol Res Pract; 2008; 204(9):683-7. PubMed ID: 18462891
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
25. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of preoperative screening for gastric mucin secretion in cervical discharge by HIK1083-labeled latex agglutination test.
Omori M; Hashi A; Ishii Y; Yuminamochi T; Nara M; Kondo T; Hirata S; Katoh R; Hoshi K
Am J Clin Pathol; 2008 Oct; 130(4):585-94. PubMed ID: 18794052
[TBL] [Abstract][Full Text] [Related]
27. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
28. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
30. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of endocervical glandular cells with "golden-yellow" mucin on pap smear.
Hata S; Mikami Y; Manabe T
Diagn Cytopathol; 2002 Aug; 27(2):80-4. PubMed ID: 12203873
[TBL] [Abstract][Full Text] [Related]
32. Successful pregnancy in a Peutz-Jeghers syndrome patient with lobular endocervical glandular hyperplasia.
Takei Y; Fujiwara H; Nagashima T; Takahashi Y; Takahashi S; Suzuki M
J Obstet Gynaecol Res; 2015 Mar; 41(3):468-73. PubMed ID: 25257303
[TBL] [Abstract][Full Text] [Related]
33. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous adenocarcinoma of the uterine cervix.
Sasajima Y; Mikami Y; Kaku T; Kiyokawa T; Ohishi Y; Hamada T; Sasaki T; Fujita H; Moriya T; Kasamatsu T; Tsuda H
Histopathology; 2008 Oct; 53(4):487-90. PubMed ID: 18631191
[No Abstract] [Full Text] [Related]
34. Increased diagnostic accuracy of atypical glandular cells in cervical liquid-based cytology using cell blocks.
Risse EK; Holierhoek JP; Meijer-Marres EM; Ouwerkerk-Noordam E; Boon ME
Cytopathology; 2011 Aug; 22(4):253-60. PubMed ID: 20726867
[TBL] [Abstract][Full Text] [Related]
35. Biology and management of lobular endocervical glandular hyperplasia.
Miyamoto T; Kobara H; Shiozawa T
J Obstet Gynaecol Res; 2022 Dec; 48(12):3056-3067. PubMed ID: 36177810
[TBL] [Abstract][Full Text] [Related]
36. Expression of Cav-1 in tumour cells, rather than in stromal tissue, may promote cervical squamous cell carcinoma proliferation, and correlates with high-risk HPV infection.
Sun J; Gao J; Hu JB; Fan LF; Zhu XB; Subahan R; Chen HL
Oncol Rep; 2012 Jun; 27(6):1733-40. PubMed ID: 22378247
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
38. Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract: a close association with gastric metaplasia.
Mikami Y; Kiyokawa T; Sasajima Y; Teramoto N; Wakasa T; Wakasa K; Hata S
Histopathology; 2009 Jan; 54(2):184-91. PubMed ID: 19207943
[TBL] [Abstract][Full Text] [Related]
39. Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix.
Hayashi I; Tsuda H; Shimoda T; Maeshima A; Kasamatsu T; Yamada T; Tsunematsu R
Virchows Arch; 2003 Dec; 443(6):752-60. PubMed ID: 14556072
[TBL] [Abstract][Full Text] [Related]
40. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]